1257O Durability of clinical benefit and biomarkers in...

1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)

Hong, D.S., Bang, Y-J., Barlesi, F., Durm, G.A., Falchook, G.S., Govindan, R., Dy, G.K., Park, K., Strickler, J.H., Burns, T.F., Kim, J., Ang, A., Lipford, J.R., Ngarmchamnanrith, G., Anderson, A., Li
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1571
Date:
September, 2020
File:
PDF, 134 KB
2020
Conversion to is in progress
Conversion to is failed